Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of chemokines in breast cancer
Marilyn Masih, Sonam Agarwal, Rupinder Kaur, et al.
Cytokine (2022) Vol. 155, pp. 155909-155909
Closed Access | Times Cited: 21

Showing 21 citing articles:

Unveiling the Immune Microenvironment’s Role in Breast Cancer: A Glimpse into Promising Frontiers
Amalia Kotsifaki, Nektarios Alevizopoulos, Vassiliki Dimopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15332-15332
Open Access | Times Cited: 22
Environmental exposure and the role of AhR in the tumor microenvironment of breast cancer
Colleen Sweeney, Gwendal Lazennec, Christoph F.A. Vogel
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
LMAN2 interacts with HEATR3 to expedite HER2-positive breast cancer advancement and inflammation and Akt/ERK/NF-κB signaling
Sujian Xiao, Tong Yu, Fulan Yang, et al.
Biochemistry and Cell Biology (2025)
Closed Access
DNA methylation-predicted plasma protein levels and breast cancer risk
Jacob K. Kresovich, Brett M. Reid, Katie M. O’Brien, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
CXCR4/CXCL12 blockade therapy; a new horizon in TNBC therapy
Abdulrahman Qais Khaleel, Farag M. A. Altalbawy, Majid S. Jabir, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Pro-Inflammatory and Anti-Inflammatory Salivary Cytokines in Breast Cancer: Relationship with Clinicopathological Characteristics of the Tumor
Lyudmila V. Bel’skaya, Alexandra I. Loginova, Elena A. Sarf
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 10, pp. 4676-4691
Open Access | Times Cited: 12
Re-evaluation of the myoepithelial cells roles in the breast cancer progression
Anwar Shams
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications
Angela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3542-3542
Open Access | Times Cited: 2
Network Pharmacology Analysis, Molecular Docking, and In Vitro Verification Reveal the Action Mechanism of Prunella vulgaris L. in Treating Breast Cancer
Haotian Bai, Rui Wang, Yalan Li, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 9
CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
Joanna Motyka, Ewa Gacuta, Aleksandra Kicman, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 573-589
Open Access | Times Cited: 5
Tumor Microenvironment: Multiway Role in Drug Resistance
Ishfaq Majid Hurra, Mubashir J. Mintoo, Kaneez Fatima, et al.
(2024), pp. 153-181
Closed Access | Times Cited: 1
The Therapeutic Potential of Physical Exercise in Cancer: The Role of Chemokines
Glenda B. B. Buzaglo, Guilherme Defante Telles, Renato E. de Araújo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13740-13740
Open Access | Times Cited: 1
Dendritic cell-based immunity: Screening of dendritic cell subsets in breast cancer-bearing mice
Alia M Aldahlawi, Kawther S. Zaher
Journal of Microscopy and Ultrastructure (2023) Vol. 11, Iss. 3, pp. 150-160
Open Access | Times Cited: 3
A Pilot Study on Biochemical Profile of Follicular Fluid in Breast Cancer Patients
Maria Antonietta Castiglione Morelli, Assunta Iuliano, Ilenia Matera, et al.
Metabolites (2023) Vol. 13, Iss. 3, pp. 441-441
Open Access | Times Cited: 2
CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients
Joanna Motyka, Aleksandra Kicman, Monika Kulesza, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3118-3118
Open Access | Times Cited: 2
Biodetection Techniques for Quantification of Chemokines
Esther Sánchez‐Tirado, L. Agüı́, A. González, et al.
Chemosensors (2022) Vol. 10, Iss. 8, pp. 294-294
Open Access | Times Cited: 3
Role of flavonoids in inhibiting triple-negative breast cancer
Shuai Wang, Kuanyu Wang, Cheng Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Roles of Chemokines in Influencing Tumor Microenvironment in Breast Cancer
Deok‐Soo Son, Samuel E. Adunyah
IntechOpen eBooks (2024)
Closed Access
Roles of Chemokine Axes in Breast Cancer
Deok‐Soo Son, Samuel E. Adunyah
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 10
Open Access
Association of the SNPs in CCL2 and CXCL12 genes with the susceptibility to breast cancer: a case-control study in China
Dongbing Zhao, Xingxing Yu, Hong‐Li Huang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Upregulated X-C motif chemokine ligand 2 (XCL2) is associated with poor prognosis and increased immune infiltration in clear cell renal cell carcinoma
Qingqiong Cao, Daoquan Liu, Zhao Chen, et al.
Cellular Signalling (2022) Vol. 102, pp. 110556-110556
Closed Access | Times Cited: 2
Page 1

Scroll to top